Increased complement activation in human type 1 diabetes pancreata. - Wikidata - awgldk - TriplyDB

Increased complement activation in human type 1 diabetes pancreata.

Increased complement activation in human type 1 diabetes pancreata.

http://www.wikidata.org/entity/Q37278134

about

The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings The streetlight effect in type 1 diabetes Abnormalities of the Exocrine Pancreas in Type 1 Diabetes Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study.Early prediction of autoimmune (type 1) diabetes.New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation.Losing a grip on the notion of β-cell specificity for immune responses in type 1 diabetes: can we handle the truth?Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model Organ donor specimens: What can they tell us about type 1 diabetes?Type 1 diabetes cadaveric human pancreata exhibit a unique exocrine tissue proteomic profile Protective Role of Complement C3 Against Cytokine-Mediated β-Cell Apoptosis.Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes.Complement Activation in Patients With Diabetic Nephropathy.

P2860

Q27009048-6ED59311-DE77-47F5-9203-F7CED34F44E4 Q27023064-20189DB3-96B3-4122-952F-41BD3A736293 Q28086876-77B832AA-7210-4EA0-9046-1020CE7EEDC1 Q28601170-419D5118-3399-439C-8000-C5420ECF2B7E Q33854613-5CF39648-587A-4EEC-9D7D-F23A1C989F9F Q34240416-064584B7-0B72-4A38-9F68-E7420C26050D Q34393356-89ACCAF4-EC11-4115-98D3-0248F481FD38 Q36399376-12F3DCDF-6012-4666-A0E6-CAF2AC8158A7 Q36478989-625D9966-00DF-4968-AEBA-69C9289F0225 Q36970856-657DD911-8E98-4B0D-9EA1-2AA250D438AA Q38743233-FB3A2C28-A42B-490F-BC1D-B79AAF22FF03 Q40162151-538B7A06-70C7-4511-8B4D-9FBB24E36E0E Q54969005-1C80F038-9E76-4843-8447-E13F747EC03C

P2860

Increased complement activation in human type 1 diabetes pancreata.

http://www.wikidata.org/entity/Q37278134

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Increased complement activation in human type 1 diabetes pancreata.

@en

Increased complement activation in human type 1 diabetes pancreata.

@nl

type

label

Increased complement activation in human type 1 diabetes pancreata.

@en

Increased complement activation in human type 1 diabetes pancreata.

@nl

prefLabel

Increased complement activation in human type 1 diabetes pancreata.

@en

Increased complement activation in human type 1 diabetes pancreata.

@nl

P1433

Q37278134-8D9419B8-32F2-4BEE-B948-06654FB4D1B9

P1476

Q37278134-92EE40BF-DFAE-4D8B-9EB1-23D735282B08

P2093

Q37278134-6B72285A-96B8-4078-B884-AEA96FD8C945

Q37278134-C0730572-ABBA-49B6-8D47-DF542EF1F13F

Q37278134-C6A15A4F-3DAB-47FF-99D4-601B586823F2

Q37278134-EAAFD2F8-3CBA-45D8-9F57-32E76150790B

P2860

Q37278134-08F69BDD-C1F4-452C-B32B-3E7A58B69469

Q37278134-170CEA8E-D203-45EE-BC68-61098569325C

Q37278134-4A9DCB5E-A03C-4EA1-BC62-66B6AD7DEED7

Q37278134-5AFD3FA3-6A84-45AA-A79C-B1F519F832C7

Q37278134-65FB78FB-18B1-4E15-97A4-CAA8A92E1DCE

Q37278134-6F6C4362-18C4-4158-B635-3DCC7A62EBC8

Q37278134-9FBC408A-9E26-4E5D-B69C-877ADA6BE294

Q37278134-B598FA5D-0D1D-43C6-A49F-6B38546F8EA3

P304

Q37278134-BF88BD0E-7173-4BD8-8359-E3327316D0EA

P31

Q37278134-1CCCE99E-6E02-4617-8BAA-49C9E47313ED

P356

Q37278134-668F0C75-0C33-4F9F-864C-3A669C72DA16

P407

Q37278134-52A7D022-C3E9-4055-BFC3-7DD7D59AF8DC

P433

Q37278134-245CBB54-C8F3-439E-A800-A82F4D93CA67

P478

Q37278134-609722E7-1A1A-4D0D-AD79-DE738A306258

P50

Q37278134-38DFBCD9-E538-49D3-93CA-70F4A6F5AF9C

Q37278134-7E5C0E88-9964-4C70-ABDC-D99DCB084DD6

Q37278134-ACCEBA2F-5D05-4B1B-85B8-0AFB9B043AAF

P577

Q37278134-E4791D48-9D3F-4C3F-863F-05170A7ADDEB

P5875

Q37278134-6AB9947A-0135-4786-B2CC-FD1705D011B3

P698

Q37278134-8FE185B9-85C4-4D0B-BE04-CDBB082122E9

P921

Q37278134-4D7C8A80-9FCF-4FD7-A987-C37996771095

P932

Q37278134-0C7E076D-1532-4A75-908D-9A448E6E1819

P356

P1433

P1476

Increased complement activation in human type 1 diabetes pancreata.

@en

P2093

Alberto Pugliese

http://www.w3.org/2001/XMLSchema#string

Byron Croker

http://www.w3.org/2001/XMLSchema#string

Mark Atkinson

http://www.w3.org/2001/XMLSchema#string

Patrick Rowe

http://www.w3.org/2001/XMLSchema#string

P2860

Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes

Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model

Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.

Molecular basis for a link between complement and the vascular complications of diabetes

Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation.

C4d/CD34 double-immunofluorescence staining of renal allograft biopsies for assessing peritubular capillary C4d positivity.

Association between mannose-binding lectin and vascular complications in type 1 diabetes.

Can C4d Immunostaining on Endomyocardial Biopsies Be Considered a Prognostic Biomarker in Heart Transplant Recipients?

P304

3815-3817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC13-0203

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Martha Campbell-Thompson

Clive Wasserfall

P577

2013-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256664179

http://www.w3.org/2001/XMLSchema#string

P698

24041678

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3816899

http://www.w3.org/2001/XMLSchema#string